Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Potential mild effects observed in animal and in vitro models include transient fatigue, mild nausea, or digestive discomfort related to metabolic acceleration
Dual-peptide formulation for synergistic research applications BPC-157: studied for tissue-protective and cytoprotective signalling pathways TB-500: investigated for roles in cell migration and angiogenesis Flexible volume delivery with four increment options Extended stability formulation What Researchers Say Frequently Asked Questions A dual-peptide formulation of BPC-157 (a gastric-juice-derived pentadecapeptide) and TB-500 (synthetic Thymosin Beta-4), both studied in preclinical tissue-repair, angiogenesis, and matrix-remodelling research
The effectiveness of a peptide depends on its structure, sequence, and ability to interact with biological targets
Accepted April 25, 2022
This means that even when fractures are not present, our bones are in a state of perpetual remodeling
Other information about the product is contained in the safety data sheet, which we make available for inspection
